| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/AJH.2011.219 |
| P698 | PubMed publication ID | 22089109 |
| P2093 | author name string | Wei Liu | |
| Yue Li | |||
| Weimin Li | |||
| Tengfei Xu | |||
| Zhiyi Zhang | |||
| Junjun Chen | |||
| Wendan Tian | |||
| P2860 | cites work | Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents | Q33755314 |
| Protective effect of the daming capsule on impaired baroreflexes in STZ-induced diabetic rats with hyperlipoidemia | Q33777472 | ||
| Cardiac mast cells: the centrepiece in adverse myocardial remodelling | Q34410300 | ||
| Vascular chymase: pathophysiological role and therapeutic potential of inhibition | Q35676125 | ||
| Verification of the formulation and efficacy of Danggui Buxue Tang (a decoction of Radix Astragali and Radix Angelicae Sinensis): an exemplifying systematic approach to revealing the complexity of Chinese herbal medicine formulae | Q36275192 | ||
| Cardiac mast cell regulation of matrix metalloproteinase-related ventricular remodeling in chronic pressure or volume overload | Q36352668 | ||
| Chymase: a new pharmacologic target in cardiovascular disease | Q36513697 | ||
| Ca2+/calmodulin-dependent protein kinase II-dependent remodeling of Ca2+ current in pressure overload heart failure | Q36869428 | ||
| New insights into the importance of aminopeptidase A in hypertension | Q36996244 | ||
| Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy | Q37091220 | ||
| Evidence for a role of mast cells in the evolution to congestive heart failure | Q42944600 | ||
| Vasoconstrictor effect of the angiotensin-converting enzyme-resistant, chymase-specific substrate [Pro(11)(D)-Ala(12)] angiotensin I in human dorsal hand veins: in vivo demonstration of non-ace production of angiotensin II in humans | Q43760028 | ||
| Chymase Inhibition Prevents Cardiac Fibrosis and Improves Diastolic Dysfunction in the Progression of Heart Failure | Q44438460 | ||
| A role for cardiac mast cells in the pathogenesis of hypertensive heart disease | Q44595513 | ||
| Telmisartan predominantly suppresses cardiac fibrosis, rather than hypertrophy, in renovascular hypertensive rats. | Q46020958 | ||
| Cardiac mast cells mediate left ventricular fibrosis in the hypertensive rat heart. | Q46034399 | ||
| Anti-inflammatory effects of Asparagus cochinchinensis extract in acute and chronic cutaneous inflammation | Q46437232 | ||
| Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction | Q47399226 | ||
| Purification and characterization of a kinin- and angiotensin II-forming enzyme in the dog heart | Q50528204 | ||
| Quinapril decreases myocardial accumulation of extracellular matrix components in spontaneously hypertensive rats | Q71782860 | ||
| Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells | Q72591955 | ||
| Tissue Angiotensin-converting enzyme activity plays an important role in pressure overload-induced cardiac fibrosis in rats | Q77794546 | ||
| Simultaneous determination of bioactive constituents in Danggui Buxue Tang for quality control by HPLC coupled with a diode array detector, an evaporative light scattering detector and mass spectrometry | Q80675860 | ||
| ACE2 overexpression ameliorates left ventricular remodeling and dysfunction in a rat model of myocardial infarction | Q84314698 | ||
| Chronic chymase inhibition preserves cardiac function after left ventricular repair in rats | Q94608691 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 250-260 | |
| P577 | publication date | 2011-11-17 | |
| P1433 | published in | Journal of Clinical Hypertension | Q15762840 |
| P1476 | title | Qiliqiangxin improves cardiac function in spontaneously hypertensive rats through the inhibition of cardiac chymase | |
| P478 | volume | 25 |
| Q42080953 | Angiotensin-converting enzyme inhibitor does not suppress renal angiotensin II levels in angiotensin I-infused rats |
| Q36269847 | Beneficial Effects of Qili Qiangxin Capsule on Lung Structural Remodeling in Ischemic Heart Failure via TGF-β1/Smad3 Pathway |
| Q41662538 | CARDIAC DISORDER IN HEMODIALYSIS: BENEFITS OF CHINESE HERBS. |
| Q42576790 | Cardiotonic modulation in heart failure: insights from traditional Chinese medicine |
| Q35705411 | Combination Treatment With Antihypertensive Agents Enhances the Effect of Qiliqiangxin on Chronic Pressure Overload-induced Cardiac Hypertrophy and Remodeling in Male Mice |
| Q35667909 | Effects of Qili Qiangxin Capsule on AQP2, V2R, and AT1R in Rats with Chronic Heart Failure. |
| Q34891653 | Estrogen inhibits mast cell chymase release to prevent pressure overload-induced adverse cardiac remodeling |
| Q36938796 | Evidence-based chinese medicine for hypertension |
| Q38885347 | Pressure overload leads to an increased accumulation and activity of mast cells in the right ventricle |
| Q35919059 | Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction. |
| Q35571961 | Qiliqiangxin inhibits angiotensin II-induced transdifferentiation of rat cardiac fibroblasts through suppressing interleukin-6 |
| Q39754726 | Stepped collisional energy MS(All) : an analytical approach for optimal MS/MS acquisition of complex mixture with diverse physicochemical properties. |
| Q89553854 | Study protocol for a randomized controlled trial: Qiliqiangxin in heart failUre: assESsment of reduction in morTality (QUEST) |
| Q36407381 | THE AUTOCRINE ROLE OF TRYPTASE IN PRESSURE OVERLOAD-INDUCED MAST CELL ACTIVATION, CHYMASE RELEASE AND CARDIAC FIBROSIS. |
| Q47232475 | The convergence of ancient chinese medicine with modern therapeutics to prevent cardiac fibrosis |
| Q33717198 | Traditional Chinese Medication Qiliqiangxin Protects Against Cardiac Remodeling and Dysfunction in Spontaneously Hypertensive Rats |
| Q27309112 | Traditional Chinese Medication Qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice. |
| Q43147354 | Traditional Chinese medicine Qili qiangxin inhibits cardiomyocyte apoptosis in rats following myocardial infarction |
| Q41867939 | X indening oral liquid improves cardiac function of rats with chronic cardiac failure via TGF-ß1/Smad3 and p38 MAPK pathway |
Search more.